key: cord-0694105-p13ev4cg
authors: Pontiroli, Antonio E.; La Sala, Lucia; Chiumello, Davide; Folli, Franco
title: Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity -diabetes?
date: 2020-07-27
journal: Diabetes Res Clin Pract
DOI: 10.1016/j.diabres.2020.108342
sha: da44737cd2e2b4b52a2ddd284abe3dc685b64668
doc_id: 694105
cord_uid: p13ev4cg

nan

1 Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity -diabetes? Antonio E. Pontiroli 1 , Lucia La Sala 2 , Davide Chiumello 1, 3 We read with interest the paper on clinical outcomes in patients with COVID-19 and pre-existing type 2 diabetes [1] . In the COVID-19 pandemics, several patients are affected by co-morbidities such as cardiovascular diseases (CVD), diabetes, and obesity. The pathogenic mechanism is far from being understood, but recent evidence shows that the severity of SARS-CoV-2 infection is attributable, rather than to the virus itself, to pro-inflammatory cytokine storm and to exaggerated systemic inflammation, that trigger abnormal activation of coagulative cascade and thrombotic states [2] . A meta-analysis shows that patients with diabetes [DM] have an incidence of Covid-19 similar to patients without DM [3] , but DM patients show a worse prognosis [1, 4, 5] , mainly depending on hyperglycemia. If it were only a matter of metabolic control, the COVID-19 disease would not be different from previous viral SARS epidemics, in which diabetes was a risk factor for bad prognosis [6] . However, in these studies [1, 4, 5] , body mass index (BMI) is not considered; when investigated, obesity was more prevalent than diabetes [7] , and increasing evidence shows that obesity is itself a bad prognostic factor as to admission to intensive care units, invasive ventilation, and death [8, 9] . Obesity shares pro-thrombotic and pro-inflammatory patterns with DM [8, 9] , and has profound mechanical effects on respiration [10] . Therefore, we speculate that BMI and BG play an additional or synergistic role in the bad prognosis of COVID-19 in DM. Intensifying the treatment of obese patients, who are also diabetic, might be important in yielding a better prognosis.

Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Diabetes is a risk factor for the progression and prognosis of COVID-19

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Lille Intensive Care COVID-19

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Body Mass Index and ARDS severity in patients with and without SARS-CoV-2 infection

The effect of obesity on lung function